Related Experiment Video
Updated: Aug 9, 2026
A High-content Assay for Monitoring AMPA Receptor Trafficking
Published on: January 28, 2019
Methods for Investigating Transient Receptor Potential Melastatin-2 (TRPM2): A Cation Channel Activated by ADP-Ribose
1Department of Pharmaceutical and Biomedical Sciences, Rudolph H. Raabe College of Pharmacy, Ohio Northern University, Ada, OH, USA.
Abstract:
Transient receptor potential melastatin-2 (TRPM2) is an emerging chemotherapeutic target due to its involvement in poly(ADP-ribose) metabolism and the ability to induce anticancer effects after antagonism of its functions. Normally functioning as a nonspecific cation channel that is activated by free ADP-ribose, TRPM2 is involved with many cellular processes, including the induction of cell death after oxidative stress. What is becoming clear is that antagonism of TRPM2 selectively induces anticancer effects in several types of cancer. We previously demonstrated decreased growth and proliferation, increased levels of DNA damage, and the selective induction of cell death in breast cancer and melanoma cells. Due to these effects, it appears that TRPM2 has a novel role in cancer cells. Further, this novel role appears to involve nuclear function, because our studies, as well as those from other independent groups, demonstrate a nuclear localization of TRPM2 in various types of cancers. Thus, as an emerging therapeutic target, it is important to describe research techniques that can be utilized to analyze TRPM2 function, determine its effects in cancerous and noncancerous cells, and provide molecular biological methods to inhibit or downregulate its function.
Insights
Blocking the TRPM2 channel, a key player in cell death pathways, shows promise for selectively targeting cancer cells. This approach reduces cancer growth and induces cell death, highlighting TRPM2 as a novel therapeutic target.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Transient receptor potential melastatin-2 (TRPM2) is a cation channel activated by ADP-ribose.
- TRPM2 participates in cellular processes, including oxidative stress-induced cell death.
- Emerging evidence suggests TRPM2 plays a role in cancer cell proliferation and survival.
Purpose of the Study:
- To investigate the role of TRPM2 in cancer.
- To explore the potential of TRPM2 antagonism as an anticancer strategy.
- To describe methods for analyzing TRPM2 function and inhibition.
Main Methods:
- Investigated TRPM2 function in breast cancer and melanoma cells.
- Assessed effects of TRPM2 antagonism on cancer cell growth, proliferation, DNA damage, and cell death.
- Examined the cellular localization of TRPM2, including nuclear localization.
Main Results:
- TRPM2 antagonism selectively induced anticancer effects in tested cancer cells.
- Decreased cancer cell growth and proliferation were observed.
- Increased DNA damage and selective induction of cell death were demonstrated.
Conclusions:
- TRPM2 has a novel role in cancer cells, potentially involving nuclear functions.
- TRPM2 antagonism is a promising strategy for selective cancer therapy.
- Further research into TRPM2 function and inhibition is warranted.
